Expect Spravato to Have a Limited Role for Resistant Depression

August 2020

You'll hear buzz about the new controlled Rx Spravato (esketamine) nasal spray for adults with resistant depression.

Some experts already use low-dose IV ketamine infusions in these patients...since growing data suggest this may "jump-start" improvement.

Spravato is the active isomer of ketamine. Both block N-methyl-D-aspartate (NMDA) receptors.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Influenza Prepare for More Demand for Flu Vaccines in 2020-21
Infectious Diseases Save Corticosteroids for Hospitalized COVID-19 Patients on Oxygen
Bites & Stings Stick With a Simple Approach for Bug Bites and Stings
Depression Expect Spravato to Have a Limited Role for Resistant Depression
Pediatrics Use the "KIDs List" to Educate About Risky Meds in Children
Wound Care Ensure Patients With a Wound Are Protected Against Tetanus
Fungal Infections Set Expectations About Treating Toenail Fungus
Gastroenterology Address Med Concerns for Patients With Dysphagia
Women's Health Listen for Questions About Menstrual Cups
Venous Thromboembolism Weigh VTE Prevention Strategies in COVID-19
Med Safety Clarify Ambiguous Abbreviations